Among patients with asymptomatic severe aortic stenosis, early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. Full EARLY TAVR trial results:
nej.md/4hjJZRc #TCT2024